financetom
Business
financetom
/
Business
/
Solventum to buy Acera Surgical for up to $850 million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Solventum to buy Acera Surgical for up to $850 million
Nov 20, 2025 8:00 AM

Nov 20 (Reuters) - Medical device maker Solventum ( SOLV )

said on Thursday it would acquire privately held Acera

Surgical for up to $850 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TechPrecision Gets Nasdaq Noncompliance Notice Over Delayed Annual Report
TechPrecision Gets Nasdaq Noncompliance Notice Over Delayed Annual Report
Jul 22, 2024
11:19 AM EDT, 07/22/2024 (MT Newswires) -- TechPrecision ( TPCS ) said Monday it has received a non-compliance notice from the Nasdaq Stock Market for failing to timely file its annual report on Form 10-K for the fiscal year ended March 31. The company said it has until Sept. 16 to submit a plan to regain compliance, adding that the...
Summer travel boom not enough to fire up airline earnings
Summer travel boom not enough to fire up airline earnings
Jul 22, 2024
CHICAGO/LONDON (Reuters) - Record summer travel demand was tipped to translate into bumper earnings for airlines - but quarterly reports are looking less than stellar. While plenty of customers are flocking to travel destinations worldwide, airlines are finding an excess supply of seats in the price-sensitive end of the market has forced them to discount fares to fill their planes....
Clearwater Paper Focuses on Paperboard: Sells Tissue Business for $1.06B
Clearwater Paper Focuses on Paperboard: Sells Tissue Business for $1.06B
Jul 22, 2024
Clearwater Paper Corporation ( CLW ) shares are trading higher after the company inked a deal to sell its tissue business to Sofidel America Corporation for $1.06 billion, subject to adjustments for debt, cash, transaction expenses, and net working capital. The price is about six times the tissue segment’s Adjusted EBITDA for the 12 months ending March. The transaction represents the...
Bausch + Lomb Q2 Revenue Expected to Rise 15%, RBC Says
Bausch + Lomb Q2 Revenue Expected to Rise 15%, RBC Says
Jul 22, 2024
11:15 AM EDT, 07/22/2024 (MT Newswires) -- Bausch + Lomb's ( BLCO ) Q2 revenue is expected to grow nearly 15% year-over-year, helped by acquisitions, though the quarter likely continued to be influenced by foreign exchange headwinds, RBC said Monday. The eye health company is scheduled to report Q2 results July 31. RBC raised its revenue outlook to $1.19 billion...
Copyright 2023-2026 - www.financetom.com All Rights Reserved